New Pick: Repairing the Broken Relationship Between Pharmaceutical Companies and Patients
By Andy Gordon on December 9, 2021
Deal Details Startup: Responsum Health Security type: Crowd SAFE* Valuation (cap): $4.5 million Discount: 0% Minimum investment: $100 Where to invest: Republic Deadline: January 2, 2022 What do you do when your doctor and half of your friends tell you a pill is safe but the other half says it could kill you? …
Cannabis Science and the War on Drugs
By Adam Sharp on March 25, 2016
Medical cannabis is already beginning to disrupt the pharmaceutical space. As I'll explain, it has the potential to take significant market share.